Insider Trading History of Hamdy Ahmed Md

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Hamdy Ahmed Md since 2010. This trader's CIK number is 1458506. At the time of last reporting, Hamdy Ahmed Md was the See Remarks of Vincerx Pharma, Inc.. (stock ticker symbol VINC). Also see all insider trading activities at Vincerx Pharma, Inc..

Note that in the past Hamdy Ahmed MD also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Pharmacyclics Inc (PCYC) by Hamdy Ahmed Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 PCYC 0 $0 15,000 $122,999 15,000 $10,950

Yearly summary of insider trading at Vincerx Pharma, Inc. (VINC) by Hamdy Ahmed Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 VINC 22,300 $21,154 0 $0 0 $0
2022 VINC 59,480 $64,698 0 $0 0 $0
2021 VINC 6,450 $64,648 0 $0 0 $0


Insider trading activities at 2 companies by Hamdy Ahmed Md:

1. Pharmacyclics Inc (PCYC)

2. Vincerx Pharma, Inc. (VINC)

Table 1. Insider trading of Pharmacyclics Inc (PCYC) by Hamdy Ahmed Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-10-05 PCYC Sale 15,000 8.20 122,999
2010-10-05 PCYC Option Ex 15,000 .73 10,950

Table 2. Insider trading of Vincerx Pharma, Inc. (VINC) by Hamdy Ahmed Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-08-10 VINC Buy 5,400 .96 5,167
2023-08-09 VINC Buy 16,900 .95 15,987
2022-12-14 VINC Buy 35,280 .87 30,552
2022-06-23 VINC Buy 24,200 1.41 34,146
2021-12-22 VINC Buy 6,450 10.02 64,648

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hamdy Ahmed Md (See Remarks of Vincerx Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.